James Boiani has extensive experience in FDA and CLIA legal and regulatory matters, having worked with large and small medical device companies (including many in vitro diagnostic companies), pharmaceutical companies, clinical laboratories, and trade associations in the life sciences industry on a variety of FDA- and CLIA-related issues.

His practice focuses on the following:

  • Advising on FDA compliance matters, with an emphasis on current good manufacturing practices (“cGMPs”) and quality systems; post-market surveillance and safety reporting; recalls; and advertising and promotion
  • Representing clients in the FDA product approval and clearance process (e.g., NDAs, BLAs, PMAs, 510(k)s, and CLIA waivers)
  • Identifying and capturing regulatory opportunities in product development and lifecycle management
  • Ensuring clinical laboratory regulatory compliance (e.g., CLIA compliance)

His experience includes:

  • Assisting companies in pre-enforcement situations by helping them manage FDA inspections; working on responses to FDA-483 observations, untitled letters, and warning letters; developing and implementing remediation strategies to correct compliance issues; evaluating and helping address CLIA audit findings; and advising clients on handling difficult FDA- or CLIA-related compliance issues more generally
  • Advising clients on adverse event (AE) and medical device report (MDR) reporting, recalls, and associated issues; of recent note, James has served as the primary outside legal advisor to a major medical device company for more than over two years, providing extensive support on all facets MDR reportability, recall decisions, recall communications to customers, recall reports to regulatory agencies and associated agency communications, and recall-related issues (such as root cause investigations and CAPAs), from both a case-specific and global corporate policy standpoint
  • Founding and serving as General Counsel of the Coalition for CLIA Waiver Reform, which is working to advance point-of-care diagnostic testing
  • Representing individual medical device manufacturers in matters involving CLIA waivers
  • Helping companies address advertising and promotional issues, including the review of promotional pieces, policy development regarding off-label uses and associated issues (e.g., handling unsolicited requests for off-label information and good reprint practices), the development of communication strategies, and conducting intensive advertising and promotional trainings for marketing and sales, scientists, and management
  • Working with compounding pharmacies and trade associations to address new FDA regulatory oversight and compliance matters
  • Representing and counseling clients in FDA drug, medical device, and biological approval- and clearance-associated matters, such as application submissions (i.e., NDAs, BLAs, ANDAs, PMAs, and 510(k)s), responses to FDA complete response/deficiency letters, administrative appeals of adverse FDA decisions, clinical and nonclinical trial design issues, and complex 505(b)(2) and combination drug policy issues
  • Counseling clients on issues regarding combination products (e.g., preparing requests for designation and advising on cGMPs, registration, and listing) and the development of companion diagnostics, and supporting policy initiatives of trade associations in the area of companion diagnostics
  • Advising drug developers on lifecycle management issues and opportunities
  • Assisting pharmaceutical and biotechnology firms in obtaining pediatric market exclusivities, Hatch-Waxman exclusivities, and patent term extensions
  • Representing clients in matters involving drug and medical device development (i.e., IND and IDE issues) and other pre-approval and pre-clearance issues (e.g., Emergency Use Authorizations)
  • Representing small and start-up biotechnology firms pursuing FDA user fee waivers, and advising clients on user fee issues

James has also worked for the Veterans Pro Bono Consortium, which provides free legal services to veterans.

Prior to becoming a lawyer, James earned degrees in chemistry from the Massachusetts Institute of Technology and Cornell University, and worked as an environmental regulatory consultant. In the fall of 2018, James returned to Cornell as a guest lecturer, co-teaching digital health law at Cornell Tech.

Focus Areas



  • George Mason University School of Law (J.D.)
  • Cornell University (M.S.)
  • Massachusetts Institute of Technology (B.S.)

Professional & Community Involvement

  • American Bar Association




Jump to Page

Privacy Preference Center

When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer.

Strictly Necessary Cookies

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

Performance Cookies

These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.